
Sinovac Receives Nasdaq Notice for Late Filing of 2025 Half-Year Report
Sinovac Receives Nasdaq Notification Regarding Late Filing of 2025 Half-Year Report Sinovac Biotech Ltd. a leading provider of biopharmaceutical products in China, today announced that it has received a notification letter dated January 2, 2026 (the “Notification Letter”) from Nasdaq…












